Ginkgo Bioworks Forum: Community User: NILUIS

schaut gut aus aktuell

Man sagt die 2 Amazon

Glaube ich nicht

Ich finde schon, dass es nach Abverkauf aussieht. Leider …

https://aktien-mag.de/blog/ginkgo-bioworks-hebt-prognose-nach-gemischten-q2-ergebnissen-an/p-82034

+26% jetzt

Jetzt +18% 😀😀🤩🤩🤩

Freue mich auf morgen😀😀

Wer von Euch ist mit dabei?

Morgen haben wir spass🤩🤩🤩😀😀

+15% nachböslich😀😀🤩🤩

Besser als erwartet🤩🤩😀😀

Sehr gute zahlen🤩🤩🤩

Ginkgo Bioworks Holdings GAAP EPS of -$0.41 misses by $0.27, revenue of $144.62M beats by $67.01M https://seekingalpha.com/news/3873112-ginkgo-bioworks-holdings-gaap-eps-of-0_41-misses-0_27-revenue-of-144_62m-beats-67_01m • Ginkgo Bioworks Holdings press release (NYSE:DNA): Q2 GAAP EPS of -$0.41 misses by $0.27. • Revenue of $144.62M (+231.4% Y/Y) beats by $67.01M. • Shares +14%. • FY 2022 Outlook: Ginkgo continues to expect to add 60 new Cell Programs to the Foundry platform in 2022 • Ginkgo further revised its expectation for total revenue from $375 – $390 million to $425 –$440 million in 2022 vs. consensus of $384.53 million. • Ginkgo continues to expect Foundry revenue of $165 – $180 million in 2022 • While Biosecurity remains an uncertain business, based on strong year-to-date performance Ginkgo now expects Biosecurity revenue in 2022 of at least $260 million

Ginkgo Bioworks Reports Second Quarter 2022 Financial Results https://investors.ginkgobioworks.com/news/news-details/2022/Ginkgo-Bioworks-Reports-Second-Quarter-2022-Financial-Results/ $145 million of Total revenue in Q2 2022, representing 231% growth over Q2 2021 13 new Cell Programs added in Q2 2022, representing 86% growth over Q2 2021 Pending acquisitions of Zymergen and Bayer's West Sacramento agricultural biologicals capabilities expected to enable new growth opportunities in the coming years Approximately $1.4 billion cash balance provides continued multi-year runway as Ginkgo drives towards profitability ...